Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Miptenalimab
Trade Name
Synonyms BI 754111|BI754111|BI-754111
Drug Descriptions

Miptenalimab (BI 754111) is a monoclonal antibody that targets LAG3 and inhibits binding of MHC II molecules to increase cytokine production by T-cells and prevent tumor growth (AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4547).

DrugClasses Immune Checkpoint Inhibitor 148 LAG3 Antibody 18
CAS Registry Number 2245092-03-7
NCIT ID C150403


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BI 907828 + Ezabenlimab + Miptenalimab BI 907828 Ezabenlimab Miptenalimab 0 1
Ezabenlimab + Miptenalimab Ezabenlimab Miptenalimab 0 0
Miptenalimab Miptenalimab 0 2

Additional content available in CKB BOOST